GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Total Tax Payable

Y-Biologics (XKRX:338840) Total Tax Payable : ₩0 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Total Tax Payable?

Y-Biologics's Total Tax Payable for the quarter that ended in Mar. 2024 was ₩0 Mil.

Y-Biologics's annual Total Tax Payable stayed the same from Dec. 2020 (₩0 Mil) to Dec. 2021 (₩0 Mil) but then increased from Dec. 2021 (₩0 Mil) to Dec. 2022 (₩84 Mil).


Y-Biologics Total Tax Payable Historical Data

The historical data trend for Y-Biologics's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Total Tax Payable Chart

Y-Biologics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Tax Payable
Get a 7-Day Free Trial - - - - 84.38

Y-Biologics Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Tax Payable Get a 7-Day Free Trial Premium Member Only - 70.38 - - -

Y-Biologics Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.


Y-Biologics Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Y-Biologics (XKRX:338840) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR
Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines